Trial · NCT00453921
Results by group28
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 28
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Neuropsychological Assessment, CVLT-II | Placebo Both Conditions | 51.3 | Standard Deviation 1.9 | units on a scale | |
| Neuropsychological Assessment, CVLT-II | Active Drug/Active Therapy | 51.8 | Standard Deviation 2.1 | units on a scale | |
| Neuropsychological Assessment, CVLT-II | Active Drug/Placebo Therapy | 51.9 | Standard Deviation 1.9 | units on a scale | |
| Neuropsychological Assessment, CVLT-II | Placebo Drug/Active Therapy | 57.2 | Standard Deviation 2.0 | units on a scale | |
| Neuropsychological Assessment - CPT, Distractibility Condition (Reaction Time) | Placebo Both Conditions | 426.4 | Standard Deviation 15.3 | units on a scale | |
| Neuropsychological Assessment - CPT, Distractibility Condition (Reaction Time) | Active Drug/Active Therapy | 394.7 | Standard Deviation 17.3 | units on a scale | |
| Neuropsychological Assessment - CPT, Distractibility Condition (Reaction Time) | Active Drug/Placebo Therapy | 416.6 | Standard Deviation 15.9 | units on a scale | |
| Neuropsychological Assessment - CPT, Distractibility Condition (Reaction Time) | Placebo Drug/Active Therapy | 413.0 | Standard Deviation 17.3 | units on a scale | |
| Functional MRI Task Performance and Brain Activation (Change From Baseline to Post-treatment) | Placebo Both Conditions | -4.46 | Standard Deviation 30.8 | percentage of correct targets (adjusted) | |
| Functional MRI Task Performance and Brain Activation (Change From Baseline to Post-treatment) | Active Drug/Active Therapy | 4.69 | Standard Deviation 26.8 | percentage of correct targets (adjusted) | |
| Functional MRI Task Performance and Brain Activation (Change From Baseline to Post-treatment) | Active Drug/Placebo Therapy | 4.86 | Standard Deviation 29.5 | percentage of correct targets (adjusted) | |
| Functional MRI Task Performance and Brain Activation (Change From Baseline to Post-treatment) | Placebo Drug/Active Therapy | -0.36 | Standard Deviation 23.4 | percentage of correct targets (adjusted) | |
| Change in Anterior Cingulate Gyrus Activation During Working Memory Processing (3-back > 0-back Condition) From Baseline to Post-intervention | Placebo Both Conditions | -0.31 | Standard Deviation .36 | units on a scale | |
| Change in Anterior Cingulate Gyrus Activation During Working Memory Processing (3-back > 0-back Condition) From Baseline to Post-intervention | Active Drug/Active Therapy | 0.09 | Standard Deviation .36 | units on a scale | |
| Change in Anterior Cingulate Gyrus Activation During Working Memory Processing (3-back > 0-back Condition) From Baseline to Post-intervention | Active Drug/Placebo Therapy | 0.20 | Standard Deviation .42 | units on a scale | |
| Change in Anterior Cingulate Gyrus Activation During Working Memory Processing (3-back > 0-back Condition) From Baseline to Post-intervention | Placebo Drug/Active Therapy | 0.05 | Standard Deviation .27 | units on a scale | |
| Change in Left Middle/Inferior Frontal Activation During Working Memory Processing (3-back > 0-back Condition) From Baseline to Post-intervention | Placebo Both Conditions | -0.16 | Standard Deviation .20 | units on a scale | |
| Change in Left Middle/Inferior Frontal Activation During Working Memory Processing (3-back > 0-back Condition) From Baseline to Post-intervention | Active Drug/Active Therapy | 0.04 | Standard Deviation .15 | units on a scale | |
| Change in Left Middle/Inferior Frontal Activation During Working Memory Processing (3-back > 0-back Condition) From Baseline to Post-intervention | Active Drug/Placebo Therapy | 0.07 | Standard Deviation .24 | units on a scale | |
| Change in Left Middle/Inferior Frontal Activation During Working Memory Processing (3-back > 0-back Condition) From Baseline to Post-intervention | Placebo Drug/Active Therapy | .10 | Standard Deviation .21 | units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00453921/results